Team Novo Nordisk announce extended partnership with Novo Nordisk for five additional years

Key Takeaways:

• Team Novo Nordisk is the only all-diabetes professional cycling team.
• The new contract extends the existing 2023–2026 deal through 2031.
• World Diabetes Day served as the platform for this major announcement.
• This marks the longest partnership extension in the team’s history.
• The partnership began in 2012 and aims to transform views on diabetes worldwide.

New Partnership Chapter

Team Novo Nordisk has announced the continuation of its pioneering collaboration with global healthcare leader Novo Nordisk. The renewed agreement, revealed on World Diabetes Day, lengthens the current contract from 2023–2026 by five more years, pushing its end date to 2031. This marks a historic development for Team Novo Nordisk, as it stands as the longest extension in its history.

Shared Vision Since 2012

Since the partnership began in 2012, Team Novo Nordisk—the world’s first all-diabetes professional cycling team—and Novo Nordisk have worked jointly to challenge prevailing perceptions surrounding diabetes. Anchored by their unified vision, the two organizations set out to show that athletes with diabetes can compete at the highest levels in their sport, delivering a powerful testament to the capabilities of people living with this condition.

A Significant World Diabetes Day Announcement

The timing of this contract renewal on World Diabetes Day underscores its importance for the global diabetes community. By linking the news to a day dedicated to awareness and advocacy, Team Novo Nordisk and Novo Nordisk further highlight their mission to improve lives, provide inspiration, and offer concrete examples of what is possible for individuals managing diabetes.

Looking to 2031

With this five-year extension, both parties reaffirm their commitment to encouraging patients, fans, and medical professionals to envision a brighter future for those living with the condition. The extended agreement sets the stage for continued achievements and stories of triumph, both on and off the cycling track, as the team strives to champion new ways of thinking about diabetes care and empowerment.

Driving Change and Inspiration

Underpinning the renewed partnership is a philosophy of determination and perseverance. From the cyclists, who keep pushing boundaries, to Novo Nordisk, which plays a leading role in healthcare advancements, the collaboration carries forward a shared hope for a world where diabetes is better understood and effectively managed. Their ongoing efforts promise to draw worldwide attention, further igniting the conversation around diabetes care through 2031 and beyond.